Citigroup Inc Inmune Bio, Inc. Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 10,120 shares of INMB stock, worth $21,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,120
Previous 10,831
6.56%
Holding current value
$21,859
Previous $50,000
58.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INMB
# of Institutions
91Shares Held
6.87MCall Options Held
202KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$1.87 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$1.79 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.76 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.29 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$825,2080.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $38.8M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...